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Rotavirus Vaccine Workshop Held
More than 125 participants from at least 15
countries attended the Fifth Rotavirus Vaccine
Workshop at the Centers for Disease Control and
Prevention (CDC) in Atlanta, Georgia, October
16-17, 1995.
Rotavirus has emerged as the most important
cause of severe diarrhea in children worldwide. It
is a problem not only in developing countries,
where it kills an estimated 870,000 children each
year, but also in the United States, where it re-
mains the most important single cause of hospi-
talization or clinic visits for childhood diarrhea.
Moreover, although studies from many coun-
tries indicate that only four serotypes are pre-
dominant worldwide, some strains at every site
studied cannot be serotyped. In some countries
such as India, the diversity of strains is extensive.
Further studies are needed to define the extent of
cross-protection against these strains that is in-
duced by the vaccine to determine whether addi-
tional antigens need to be included in vaccines for
such areas.
This workshop included sessions on epidemiol-
ogy, virology, pathogenesis and immunity, and vac-
cines currently being tested. Each session had
numerous presentations by leaders in the field of
rotavirus research. Researchers reported that sev-
eral live oral rotavirus vaccines, based on animal
strains of rotavirus combined with reassortant
strains, have been tested in field trials in children.
These appear to protect American children against
rotavirus and are more efficacious against severe
disease. These vaccines like natural protection,
are not 100% protective so many investigators are
exploring alternative approaches to vaccines such
as the use of virus-like particles, native DNA, and
microencapsulation of antigens.
No published volume of proceedings from the
workshop is planned, but a supplemental issue of
the Journal of Infectious Diseases scheduled for
early 1996 will contain papers from the meeting.
The workshop was held under the auspices of
the National Institutes of Health, Emory Univer-
sity School of Medicine, and the World Health
Organization.
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International Conference Addresses
Preparedness for Emerging Strains
of Pandemic Influenza
An international meeting on pertinent issues
related to recognizing, identifying, and controlling
newly emerging strains of pandemic influenza
was held in Bethesda, Maryland, December 11–
13, 1995. The conference, “Pandemic Influenza:
Confronting a Reemergent Threat,” was spon-
sored by the National Institutes of Health, the
University of Michigan, the Centers for Disease
Control and Prevention, the Food and Drug Ad-
ministration, the U.S.-Japan Cooperative Medical
Science Program, and the World Health
Organization.
Epidemic strains of influenza cause infections
almost every year throughout the world because
of continuous minor genetic changes in the virus.
However, periodically a major change occurs, such
as reassortment between mammalian and avian
strains of the virus. These pandemic strains are
novel to the human immune system and, there-
fore, can cause substantial disease worldwide. The
conference concentrated on issues that would be
crucial to controlling an influenza pandemic.
Plenary and workshop sessions examined the
following topics: Can pandemics be predicted?
What are the specific approaches for pandemic
control? What are the advantages and limitations
of vaccines and antiviral agents? The workshops
also focused on factors contributing to the emer-
gence of pandemic strains and various aspects of
surveillance, such as the adequacy of current
global surveillance structure for early identifica-
tion of a pandemic strain, the use of virologic and
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fied, and the rapid exchange of information glob-
ally. The following immunologic and molecular
questions were addressed as well: What basic
research advances would allow us to respond more
rapidly after the next human pandemic strain is
detected? Is the presence of novel influenza A virus
in pigs a predictor of the next influenza pandemic?
Is an H2 influenza virus the next human pan-
demic subtype or are H7 viruses equally possible?
Also discussed were the practical issues of vaccine
needs, production, and distribution.
Conference participants then reviewed interna-
tional pandemic plans and the U.S. pandemic plan
being prepared by the Federal Interagency Group
on Pandemic Preparedness.
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Course Offered on Clinical and
Pathologic Features of Emerging
Infections
The Armed Forces Institute of Pathology
(AFIP), Emory University, and the Centers for
Disease Control and Prevention (CDC) are cospon-
soring a course on emerging and reemerging
pathogens. The course will be taught in Atlanta,
Georgia from April 27 to May 1 and will discuss
the epidemiology, clinical features, pathology, and
pathogenesis of such diseases as plague, Lyme
disease, Kaposi sarcoma, microsporidiosis, Buruli
ulcer, ehrlichiosis, hantavirus pulmonary syn-
drome, and Ebola virus infection. Emerging drug
resistance in pneumococci and other streptococcal
infections will also be discussed.
The course is designed for pathologists, epide-
miologists, infectious disease physicians, veteri-
narians, microbiologists, parasitologists, and
others interested in the pathology as well as the
emergence of infectious diseases. The course, to be
held at the Emory Conference Center Hotel, will
provide 38 hours of Category I CME credit and will
consist of 32 hours of lectures with open discussion
periods, 6 hours of glass and color slide review, and
a visit to CDC laboratories. For more information,
contact the course director, Center for Advanced
Medical Education, AFIP, Washington, D.C.
20306-6000 (phone: 800-577-3749 or 301-295-
7921; fax: 301-427-5001).
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NASA Sponsors Symposium on
Remote Sensing and Control of
Insect-Transmitted Diseases 
Health officials and disease control experts met
November 28-30 in Baltimore, Maryland, for a
symposium on the use of satellites to monitor and
control insect-transmitted diseases.
Sponsored by the National Aeronautics and
Space Administration (NASA) and the Third
World Foundation of North America, the
symposium was held to inform government offi-
cials from various countries of NASA’s scientific
and technologic capabilities for detecting, moni-
toring, and improving the control of diseases.
Health ministers and medical directors from more
than 20 countries, including Bangladesh, Belize,
China, Ghana, Indonesia, Kenya, Malaysia, Nige-
ria, Peru, and Rwanda, attended.
The symposium featured discussions on the
economics of disease surveillance, deforestation,
and urbanization. The keynote address, “The re-
surgence of vector-borne infectious diseases as
major public health problems in the 1990s,” was
given by Duane Gubler, director, Division of Vec-
tor-Borne Infectious Diseases, National Center for
Infectious Diseases, Centers for Disease Control
and Prevention (CDC). Participants also dis-
cussed possible joint activities between NASA and
interested countries. Further information can be
obtained from NASA’s Office of Life and Micro-
gravity Sciences, Washington, D.C., which man-
ages the agency’s global monitoring and human
health research program in conjunction with the
National Institute of Allergy and Infectious Dis-
eases, National Institutes of Health, and CDC.
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